Zobrazeno 1 - 10
of 100
pro vyhledávání: '"de Langen AJ"'
Publikováno v:
OncoTargets and Therapy, Vol Volume 10, Pp 4535-4541 (2017)
Ittai B Muller,1 Adrianus J de Langen,2,3 Elisa Giovannetti,4,5 Godefridus J Peters4 1Department of Clinical Chemistry, 2Department of Pulmonology, VU University Medical Center, 3Department of Thoracic Oncology, Netherlands Cancer Institute, 4Departm
Externí odkaz:
https://doaj.org/article/30fbc900c360466e8620d78c38529795
Autor:
Kramer, GM, Liu, Y, De Langen, AJ, Jansma, EP, Trigonis, I, Asselin, M-C, Jackson, A, Kenny, L, Aboagye, EO, Hoekstra, OS, Boellaard, R, QuIC-ConCePT consortium
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging, 45(6), 951-961. Springer Verlag
Kramer, G M, Liu, Y, de Langen, A J, Jansma, E P, Trigonis, I, Asselin, M-C, Jackson, A, Kenny, L, Aboagye, E O, Hoekstra, O S & Boellaard, R 2018, ' Repeatability of quantitative 18F-FLT uptake measurements in solid tumors: an individual patient data multi-center meta-analysis ', European Journal of Nuclear Medicine and Molecular Imaging . https://doi.org/10.1007/s00259-017-3923-x
Kramer, G M, Liu, Y, de Langen, A J, Jansma, E P, Trigonis, I, Asselin, M C, Jackson, A, Kenny, L, Aboagye, E O, Hoekstra, O S, Boellaard, R & on behalf of the QuIC-ConCePT Consortium 2018, ' Repeatability of quantitative 18 F-FLT uptake measurements in solid tumors : an individual patient data multi-center meta-analysis ', European Journal of Nuclear Medicine and Molecular Imaging, vol. 45, no. 6, pp. 951-961 . https://doi.org/10.1007/s00259-017-3923-x
European Journal of Nuclear Medicine and Molecular Imaging
Kramer, G M, Liu, Y, de Langen, A J, Jansma, E P, Trigonis, I, Asselin, M-C, Jackson, A, Kenny, L, Aboagye, E O, Hoekstra, O S & Boellaard, R 2018, ' Repeatability of quantitative 18F-FLT uptake measurements in solid tumors: an individual patient data multi-center meta-analysis ', European Journal of Nuclear Medicine and Molecular Imaging . https://doi.org/10.1007/s00259-017-3923-x
Kramer, G M, Liu, Y, de Langen, A J, Jansma, E P, Trigonis, I, Asselin, M C, Jackson, A, Kenny, L, Aboagye, E O, Hoekstra, O S, Boellaard, R & on behalf of the QuIC-ConCePT Consortium 2018, ' Repeatability of quantitative 18 F-FLT uptake measurements in solid tumors : an individual patient data multi-center meta-analysis ', European Journal of Nuclear Medicine and Molecular Imaging, vol. 45, no. 6, pp. 951-961 . https://doi.org/10.1007/s00259-017-3923-x
European Journal of Nuclear Medicine and Molecular Imaging
Introduction 3′-deoxy-3′-[18F]fluorothymidine (18F–FLT) positron emission tomography (PET) provides a non-invasive method to assess cellular proliferation and response to antitumor therapy. Quantitative 18F–FLT uptake metrics are being used f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5746866e6f87887f1f97862883bc3065
https://research.vumc.nl/en/publications/c6e13ed1-6ce0-4fb0-a1aa-8f07a20bad01
https://research.vumc.nl/en/publications/c6e13ed1-6ce0-4fb0-a1aa-8f07a20bad01
Publikováno v:
Journal of Nuclear Medicine; Oct2020, Vol. 61 Issue 10, p1034-1037, 4p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Oncologist; Jun2008, Vol. 13 Issue 6, p631-644, 14p
Publikováno v:
Journal of Thoracic Oncology; 2007 Supplement 4, Vol. 2, pS187-S188, 2p
Autor:
Miedema IHC; Department of Medical Oncology, Amsterdam UMC Locatie VUmc, Amsterdam, The Netherlands.; Imaging and Biomarkers, Cancer Centre Amsterdam, Amsterdam, The Netherlands., Pouw JEE; Department of Medical Oncology, Amsterdam UMC Locatie VUmc, Amsterdam, The Netherlands.; Imaging and Biomarkers, Cancer Centre Amsterdam, Amsterdam, The Netherlands., Kwakman A; Department of Medical Oncology, Amsterdam UMC Locatie VUmc, Amsterdam, The Netherlands.; Imaging and Biomarkers, Cancer Centre Amsterdam, Amsterdam, The Netherlands., Zwezerijnen GJC; Imaging and Biomarkers, Cancer Centre Amsterdam, Amsterdam, The Netherlands.; Department of Radiology and Nuclear Medicine, Amsterdam UMC Location VUmc, Amsterdam, The Netherlands., Huisman MC; Imaging and Biomarkers, Cancer Centre Amsterdam, Amsterdam, The Netherlands.; Department of Radiology and Nuclear Medicine, Amsterdam UMC Location VUmc, Amsterdam, The Netherlands., Timmer FEF; Imaging and Biomarkers, Cancer Centre Amsterdam, Amsterdam, The Netherlands.; Department of Radiology and Nuclear Medicine, Amsterdam UMC Location VUmc, Amsterdam, The Netherlands., van de Ven R; Otolaryngology / Head and Neck Surgery, Amsterdam UMC - Locatie VUMC, Amsterdam, The Netherlands.; Cancer Biology and Immunology, Cancer Centre Amsterdam, Amsterdam, The Netherlands., de Gruijl TD; Department of Medical Oncology, Amsterdam UMC Locatie VUmc, Amsterdam, The Netherlands.; Cancer Biology and Immunology, Cancer Centre Amsterdam, Amsterdam, The Netherlands., Hospers GAP; Medical Oncology, University Medical Centre Groningen, Groningen, The Netherlands., de Langen AJ; NKI, Amsterdam, The Netherlands., Menke-van der Houven van Oordt CW; Department of Medical Oncology, Amsterdam UMC Locatie VUmc, Amsterdam, The Netherlands c.menke@amsterdamumc.nl.; Imaging and Biomarkers, Cancer Centre Amsterdam, Amsterdam, The Netherlands.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2024 Jun 17; Vol. 12 (6). Date of Electronic Publication: 2024 Jun 17.
Autor:
Samsom KG; Department of Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Bosch LJW; Department of Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Schipper LJ; Department of Molecular Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Office Jaarbeurs Innovation Mile (JIM), Utrecht, the Netherlands., Schout D; Department of Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Roepman P; Hartwig Medical Foundation, Science Park, Amsterdam, the Netherlands., Boelens MC; Department of Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Lalezari F; Department of Radiology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Klompenhouwer EG; Department of Radiology, Netherlands Cancer Institute, Amsterdam, the Netherlands., de Langen AJ; Department of Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Buffart TE; Department of Medical Oncology, Amsterdam UMC, Amsterdam, the Netherlands., van Linder BMH; Department of Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands., van Deventer K; Department of Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands., van den Burg K; Department of Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Unmehopa U; Department of Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Rosenberg EH; Department of Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Koster R; Department of Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Hogervorst FBL; Department of Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands., van den Berg JG; Department of Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Riethorst I; Hartwig Medical Foundation, Science Park, Amsterdam, the Netherlands., Schoenmaker L; Hartwig Medical Foundation, Science Park, Amsterdam, the Netherlands., van Beek D; Hartwig Medical Foundation, Science Park, Amsterdam, the Netherlands., de Bruijn E; Hartwig Medical Foundation, Science Park, Amsterdam, the Netherlands., van der Hoeven JJM; Hartwig Medical Foundation, Science Park, Amsterdam, the Netherlands., van Snellenberg H; Hartwig Medical Foundation, Science Park, Amsterdam, the Netherlands., van der Kolk LE; Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands., Cuppen E; Oncode Institute, Office Jaarbeurs Innovation Mile (JIM), Utrecht, the Netherlands.; Hartwig Medical Foundation, Science Park, Amsterdam, the Netherlands.; Center for Molecular Medicine, University Medical Centre Utrecht, Utrecht, the Netherlands., Voest EE; Department of Molecular Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Office Jaarbeurs Innovation Mile (JIM), Utrecht, the Netherlands.; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Meijer GA; Department of Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands. g.meijer@nki.nl., Monkhorst K; Department of Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
Publikováno v:
Nature protocols [Nat Protoc] 2024 Mar; Vol. 19 (3), pp. 700-726. Date of Electronic Publication: 2023 Dec 13.
Autor:
van Veggel BAMH; Department of Thoracic Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., van der Wekken AJ; Department of Pulmonary Diseases, University of Groningen and University Medical Center Groningen, Groningen, the Netherlands., Paats MS; Department of Pulmonary Diseases, Erasmus University Medical Center Cancer Institute, Rotterdam, the Netherlands., Hendriks LEL; Department of Pulmonary Diseases, Maastricht University Medical Center, Maastricht, the Netherlands., Hashemi SMS; Department of Pulmonary Medicine, Amsterdam University Medical Centers, Vrije Universiteit Medical Center, and Cancer Center Amsterdam, Amsterdam, the Netherlands., Daletzakis A; Department of Biometrics, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., van den Broek D; Department of Laboratory Medicine, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., Bosch LJW; Department of Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., Monkhorst K; Department of Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., Smit EF; Department of Thoracic Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.; Department of Pulmonary Diseases, Leiden University Medical Center, Leiden, the Netherlands., de Langen AJ; Department of Thoracic Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
Publikováno v:
Cancer [Cancer] 2024 Mar 01; Vol. 130 (5), pp. 683-691. Date of Electronic Publication: 2023 Oct 31.
Autor:
Lin L; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Barkman HJ; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Smit EF; Department of Thoracic Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands.; Department of Pulmonology, Leiden University Medical Center, Leiden, The Netherlands., de Langen AJ; Department of Thoracic Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands., Steeghs N; Department of Medical Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands., Beijnen JH; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Department of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands., Huitema ADR; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Department of Pharmacology, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands; and.; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Publikováno v:
Therapeutic drug monitoring [Ther Drug Monit] 2024 Feb 01; Vol. 46 (1), pp. 73-79. Date of Electronic Publication: 2023 Jun 20.